Hi OSR, the quarterly was what prompted my question. Hard to say with any certainty, but it does seem to hint at holding on to Jpang doesn't it? Which will mean a $1m hit unless a new deal gets dealt to expand the mill to handle the metalurgy, that will potentially postpone the capital outlay. I think I said a long while back that I reckon it was a good deal based on what (little) I could dig up on the mispec work that hasn't made any Augur announcements.
Regarding CR,I personally think it would be best for them to hit the institutions again. I know that dilutes for shareholders, but as you say there's a heap of activity at the moment that is costing, some big announcements and big decisions on the way. Get the cash and keep charging I reckon, especially now the SP is skulking around the 0.20 mark again. But again, it might depend on the plan. Instos might not be so keen if they have to throw a mil at a small fry mill, while holders might be more prepared to chip in.
I'm no expert, but hitting the market on a thinly traded stock (excepting the spike mid year) seems to carry a bit more risk...
I'm hoping for a quick run on another play so I can punch out and buy back in to AUK at a 50% discount ... let you know if I succeed or fail! I never post a sentiment, but its looking like time for me to think about a buy. Just need a bit more info on cash plans ....
COLCOM
- Forums
- ASX - By Stock
- run out of buyers
Hi OSR, the quarterly was what prompted my question. Hard to say...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AUK (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online